4.6 Article

Endogenous ADP-ribosylation of elongation factor-2 by interleukin-1β

Journal

MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 348, Issue 1-2, Pages 125-128

Publisher

SPRINGER
DOI: 10.1007/s11010-010-0646-8

Keywords

Elongation factor-2; Interleukin-1 beta; ADP-ribosylation; Cytokines; Protein synthesis

Categories

Funding

  1. Deutsche Forschungsgemeinschaft
  2. Bundesministerium fur Bildung und Forschung

Ask authors/readers for more resources

Eukaryotic elongation factor-2 (eEF-2) catalyses the motion of the growing peptide chain relative to the mRNA at the ribosomes during protein synthesis. This highly conserved G-protein is the specific target of two lethal bacterial toxins, Pseudomonas aeruginosa exotoxin A and diphtheria toxin. These toxins exert their detrimental action by ADP-ribosylating a biologically unique posttranslationally modified histidine residue (diphthamide(715)) within eEF-2, thus inactivating the enzyme. Diphthamide(715) is also the target of endogenous (mono) ADP-ribosyl transferase activity. In this article, we report the first known activator of endogenous ADP-ribosylation of eEF-2, interleukin-1 beta (IL-1 beta). Thereby, systemic inflammatory processes may link to protein synthesis regulation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available